Total Mesorectum Excision With Left Colic Artery Preservation for the Treatment of Rectal Cancer

Rectal Cancer Clinical Trial

Official title:

A Randomized Controlled Clinical Trial to Investigate the Effects of Total Mesorectum Excision With Left Colic Artery Preservation for the Treatment of Rectal Cancer

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03724591
• Other study ID #: CRSYM201810
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2019
• Est. completion date: January 2024

Study information

• Verified date: October 2018
• Source: The First Affiliated Hospital with Nanjing Medical University
• Contact: Yueming Sun, PhD
• Phone: 02568306026
• Email: jssym[@]vip.sina.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A randomized controlled clinical trial to compare the short and long term outcomes of left colic artery preservation for the treatment of Rectal Cancer

Description:

Rectal cancer is one of most frequently diagnosed cancers and one of the leading causes of cancer death around the world. Surgery remains the main treatment for rectal cancer. Anastomosis leakage (AL) is an unresolved, devastating and lethal complication after rectal cancer surgery and remains to be a serious difficulty for surgeons despite its causes, preventions and treatments having been extensively studied.

To achieve a radical dissection of lymph nodes, it is necessary to remove the central lymph nodes at the root of inferior mesenteric artery(IMA) trunk.From the perspectives of lymph nodes dissection and tension-free anastomosis, it is preferred to perform a high ligation of IMA. However, there is still a controversy whether IMA should be high ligated or not. The argument mainly focuses on whether this performance will compromise the blood perfusion of the proximal limb of the anastomosis leading to the occurrence of AL. Some studies suggested that a high ligation did not increase the rate of AL. There are still many surgeons prefer the transection of IMA distal to the left colic artery(LCA) with the intention to preserve a good blood supply of the left colon after the performance of lymph node dissection around IMA. Some studies suggests that the preservation of LCA in anterior resection for mid and low rectal cancer is associated with lower rates of AL. Further investigations are needed to resolve the controversy.

In this study, eligible patients will be randomly allocated to receive total mesorectal excision (TME) for rectal cancer either by a high ligation of IMA without preservation of left colic artery or a low ligation of IMA with preservation of left colic artery. Postoperative complications, including anastomosis leakage, anastomosis bleeding, will be recorded. Patients will be followed up every 3 months for 2 year, every 6 months for 3 years postoperatively to study the long term effects.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 600
• Est. completion date: January 2024
• Est. primary completion date: January 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Patients suitable for curative surgery over 18 years old;

• American Society of Anesthesiologists(ASA) grade I-III;

• Pathological diagnosis of rectal adenocarcinoma;

• Patients suitable for abdominalperineal resection

• Informed consent;

• No history of familial adenomatous polyposis, ulcerative colitis or Crohn's disease.

Exclusion Criteria:

• Pregnant patient;

• History of psychiatric disease;

• Use of systemic steroids;

• Simultaneous multiple primary colorectal cancer;

• Preoperative imaging examination results show:1. Tumor involves the surrounding organs and combined organ resection need to be done;2. distant metastasis;3. unable to perform R0 resection;

• History of any other malignant tumor in recent 5 years;

• Patients need emergency operation: mechanic ileus, perforation.

Related Conditions & MeSH terms

• Rectal Cancer
• Rectal Neoplasms

Intervention

Procedure:
• a high ligation of IMA
total mesorectal excision (TME) for rectal cancer by a high ligation of IMA without preservation of left colic artery
• a low ligation of IMA
total mesorectal excision (TME) for rectal cancer by a low ligation of IMA with preservation of left colic artery

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
The First Affiliated Hospital with Nanjing Medical University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Anastomosis leakage rate		30 days
Secondary	Anastomosis bleeding rate		30 days
Secondary	disease-free survival		5 years
Secondary	local recurrence rate		5 years
Secondary	operative time		1 day
Secondary	number of lymph nodes retrieved		1 day
Secondary	postoperative quality of life as assessed by EORTC QLQ-C30 questionnaire	Compare the differences in postoperative quality of life of patients treated with these two regimens using EORTC QLQC30 questionnaire	5 years